Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
88
Views
6
CrossRef citations to date
0
Altmetric
Original Research

A novel gene-pair signature for relapse-free survival prediction in colon cancer

Peng-fei Chen1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected];3 Department of Gastroenterology, The Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China
,
Fan Wang1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Zi-xiong Zhang4 Department of Otolaryngology, The Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China
,
Jia-yan Nie1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Lan Liu1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Jue-rong Feng1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Rui Zhou1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Hong-ling Wang1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]
,
Jing Liu1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
&
Qiu Zhao1 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China, [email protected]; [email protected];2 Hubei Clinical Center & Key Lab of Intestinal & Colorectal Diseases, Wuhan 430071, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
 show all
Pages 4145-4153 | Published online: 03 Oct 2018

References

  • TorreLASiegelRLWardEMJemalAGlobal Cancer Incidence and Mortality Rates and Trends--An UpdateCancer Epidemiol Biomarkers Prev2016251162726667886
  • SeoSILimSBYoonYSComparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patientsJ Surg Oncol2013108191323754582
  • KawaguchiTKomatsuSIchikawaDComparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinomaAnticancer Res20133383461346523898120
  • O’ConnellJBMaggardMAKoCYColon cancer survival rates with the new American Joint Committee on Cancer sixth edition stagingJ Natl Cancer Inst200496191420142515467030
  • MarisaLde ReynièsADuvalAGene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valuePLoS Med2013105e100145323700391
  • GuinneyJDienstmannRWangXThe consensus molecular subtypes of colorectal cancerNat Med201521111350135626457759
  • AlderdiceMRichmanSDGollinsSProspective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsiesJ Pathol20182451192829412457
  • DaiWLiYMoSA robust gene signature for the prediction of early relapse in stage I-III colon cancerMol Oncol201812446347529377588
  • TianXZhuXYanTRecurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancerMol Oncol201711111544156028796930
  • XiongYWangRPengLAn integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancerOncotarget2017849854638547829156733
  • AlajezNMLarge-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant RecurrencePLoS One20161112e016745527935967
  • LiBCuiYDiehnMLiRDevelopment and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung CancerJAMA Oncol20173111529153728687838
  • PengPLZhouXYYiGDChenPFWangFDongWGIdentification of a novel gene pairs signature in the prognosis of gastric cancerCancer Med20187234435029282891
  • HanLOLiXYCaoMMCaoYZhouLHDevelopment and validation of an individualized diagnostic signature in thyroid cancerCancer Med2018741135114029522282
  • WangFChangYLiJStrong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysisDig Liver Dis2017491707627876500
  • BatheOFFarshidfarFFrom genotype to functional phenotype: unraveling the metabolomic features of colorectal cancerGenes20145353656025055199
  • ChoWCMicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapyInt J Biochem Cell Biol20104281273128120026422
  • TsaiHLYangIPHuangCWClinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resectionTransl Res2013162425826823933284
  • ThompsonEMKeirSTVenkatramanTThe role of angiogenesis in Group 3 medulloblastoma pathogenesis and survivalNeuro Oncol20171991217122728379574
  • SunLLiuMSunGCNotch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2J Cancer20167111388139527471554
  • IshiiJYazawaTChibaTPROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer CellsEndocrinology201615731289129826760117
  • TaurielloDVFPalomo-PonceSStorkDTGFβ drives immune evasion in genetically reconstituted colon cancer metastasisNature2018554769353854329443964
  • CaiMSunXWangWDisruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cellsCancer Lett2018421829329458144
  • DahabiehMSHaZDi PietroEPeroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosisCell Death Differ201724111912192428731463
  • FransenMNordgrenMWangBApanasetsORole of peroxisomes in ROS/RNS-metabolism: implications for human diseaseBiochim Biophys Acta2012182291363137322178243
  • Zuazo-GazteluICasanovasOUnraveling the Role of Angiogenesis in Cancer EcosystemsFront Oncol2018824830013950
  • LiLLiBChenDmiR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesisOncol Rep2015341515825955258
  • LiFZhangRLiSLiuJIDO1: An important immunotherapy target in cancer treatmentInt Immunopharmacol201747707728365507

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.